Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tobacco, Smokeless | 1 | 2023 | 10 | 0.790 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2025 | 288 | 0.780 |
Why?
|
| Parabens | 1 | 2022 | 7 | 0.740 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 98 | 0.710 |
Why?
|
| Endocrine Disruptors | 1 | 2022 | 55 | 0.700 |
Why?
|
| Metabolomics | 4 | 2024 | 493 | 0.520 |
Why?
|
| Printing, Three-Dimensional | 3 | 2025 | 88 | 0.460 |
Why?
|
| India | 4 | 2025 | 245 | 0.330 |
Why?
|
| Tablets | 3 | 2025 | 38 | 0.320 |
Why?
|
| Biomarkers | 3 | 2024 | 3405 | 0.320 |
Why?
|
| Thioridazine | 1 | 2025 | 4 | 0.240 |
Why?
|
| Gallstones | 1 | 2025 | 18 | 0.230 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2025 | 25 | 0.230 |
Why?
|
| Lamin Type A | 1 | 2025 | 13 | 0.230 |
Why?
|
| bcl-X Protein | 1 | 2025 | 32 | 0.220 |
Why?
|
| Gallbladder Neoplasms | 1 | 2025 | 15 | 0.220 |
Why?
|
| Phospholipids | 1 | 2025 | 103 | 0.220 |
Why?
|
| GATA4 Transcription Factor | 1 | 2025 | 38 | 0.220 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2025 | 38 | 0.220 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2025 | 85 | 0.220 |
Why?
|
| Metals, Heavy | 1 | 2025 | 26 | 0.220 |
Why?
|
| Alkanesulfonic Acids | 1 | 2024 | 14 | 0.220 |
Why?
|
| Groundwater | 1 | 2024 | 11 | 0.220 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2025 | 74 | 0.220 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2024 | 66 | 0.220 |
Why?
|
| Rifampin | 1 | 2025 | 120 | 0.210 |
Why?
|
| Water Pollutants, Chemical | 1 | 2024 | 37 | 0.210 |
Why?
|
| Environmental Monitoring | 1 | 2024 | 103 | 0.210 |
Why?
|
| Tamoxifen | 1 | 2025 | 350 | 0.210 |
Why?
|
| Isoniazid | 1 | 2024 | 65 | 0.210 |
Why?
|
| Fluorocarbons | 1 | 2024 | 69 | 0.210 |
Why?
|
| Doxorubicin | 1 | 2025 | 301 | 0.200 |
Why?
|
| Dengue | 1 | 2024 | 123 | 0.200 |
Why?
|
| Plant Extracts | 1 | 2024 | 139 | 0.190 |
Why?
|
| Praziquantel | 1 | 2022 | 13 | 0.190 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2025 | 300 | 0.190 |
Why?
|
| Carcinogenesis | 1 | 2025 | 357 | 0.180 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 723 | 0.180 |
Why?
|
| Phenols | 1 | 2022 | 70 | 0.180 |
Why?
|
| Benzhydryl Compounds | 1 | 2022 | 75 | 0.170 |
Why?
|
| Cattle | 1 | 2022 | 521 | 0.170 |
Why?
|
| Machine Learning | 1 | 2024 | 375 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 825 | 0.160 |
Why?
|
| Drug Liberation | 3 | 2025 | 40 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2024 | 807 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2025 | 673 | 0.150 |
Why?
|
| Chromatography, Liquid | 3 | 2024 | 240 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2024 | 3695 | 0.120 |
Why?
|
| Drug Compounding | 2 | 2025 | 41 | 0.110 |
Why?
|
| Rabbits | 2 | 2025 | 633 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 2648 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2025 | 1571 | 0.090 |
Why?
|
| Male | 7 | 2025 | 65264 | 0.080 |
Why?
|
| Animals | 4 | 2025 | 34374 | 0.080 |
Why?
|
| Humans | 8 | 2025 | 131671 | 0.080 |
Why?
|
| Female | 5 | 2025 | 71181 | 0.060 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2025 | 10 | 0.060 |
Why?
|
| MCF-7 Cells | 1 | 2025 | 209 | 0.060 |
Why?
|
| Solubility | 1 | 2025 | 118 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2025 | 119 | 0.060 |
Why?
|
| Zingiberaceae | 1 | 2024 | 3 | 0.060 |
Why?
|
| Excipients | 1 | 2024 | 13 | 0.060 |
Why?
|
| Cardiotoxicity | 1 | 2025 | 43 | 0.060 |
Why?
|
| Drinking Water | 1 | 2024 | 16 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 51 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2024 | 61 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 428 | 0.050 |
Why?
|
| Lasers | 1 | 2024 | 114 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2025 | 305 | 0.050 |
Why?
|
| Cell Survival | 1 | 2025 | 854 | 0.050 |
Why?
|
| Technology, Pharmaceutical | 1 | 2022 | 19 | 0.050 |
Why?
|
| Biological Availability | 1 | 2022 | 140 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 810 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 709 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1151 | 0.050 |
Why?
|
| Antioxidants | 1 | 2024 | 336 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 518 | 0.040 |
Why?
|
| Metabolome | 1 | 2024 | 329 | 0.040 |
Why?
|
| Cell Line | 1 | 2025 | 2605 | 0.040 |
Why?
|
| Myocardium | 1 | 2025 | 874 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 31717 | 0.040 |
Why?
|
| Rats | 1 | 2025 | 3460 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 1085 | 0.030 |
Why?
|
| Apoptosis | 1 | 2025 | 1861 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3673 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 28886 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 4683 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21256 | 0.020 |
Why?
|